Publications

Études médicales

Prevention of early ventilation-acquired pneumonia (VAP) in comatose brain-injured patients by a single dose of ceftriaxone: PROPHY-VAP study protocol, a multicentre, randomised, double-blind, placebo-controlled trial.

Dahyot-Fizelier C, Frasca D, Lasocki S, Asehnoune K, Balayn D, Guerin AL, Perrigault PF, Geeraerts T, Seguin P, Rozec B, Elaroussi D, Cottenceau V, Guyonnaud C, Mimoz O, PROPHY-VAP Study group, ATLANREA group.

BMJ open, 18 octobre 2018 ; 8(10) : e021488

Patient factors and outcomes associated with the withdrawal or withholding of life-sustaining therapies in mechanically ventilated brain-injured patients: an observational multicentre study.

Nesseler N, Roquilly A, Lasocki S, Dahyot-Fizelier C, Launey Y, Cinotti R, Hubert M, Isslame S, Perrigault PF, Geeraerts T, Mimoz O, Marhar F, Mallédant Y, Feuillet F, Asehnoune K, Seguin P, BIVILI investigators., ATLANREA group.

European journal of anaesthesiology, juin 2018 ; 35(7) : 511-518

Association between continuous hyperosmolar therapy and survival in patients with traumatic brain injury - a multicentre prospective cohort study and systematic review.

Asehnoune K, Lasocki S, Seguin P, Geeraerts T, Perrigault PF, Dahyot-Fizelier C, Paugam Burtz C, Cook F, Demeure Dit Latte D, Cinotti R, Mahe PJ, Fortuit C, Pirracchio R, Feuillet F, Sébille V, Roquilly A, ATLANREA group., COBI group.

Critical care (London, England), 28 décembre 2017 ; 21(1) : 328

Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial.

Asehnoune K, Seguin P, Allary J, Feuillet F, Lasocki S, Cook F, Floch H, Chabanne R, Geeraerts T, Roger C, Perrigault PF, Hanouz JL, Lukaszewicz AC, Biais M, Boucheix P, Dahyot-Fizelier C, Capdevila X, Mahe PJ, Le Maguet P, Paugam-Burtz C et al.

The Lancet. Respiratory medicine, août 2014 ; 2(9) : 706-16

Études para-médicales